Express Pharma - Express Pharma

Cosentyx approval is based on phase III programme demonstrating high, sustained efficacy in the skin clearance of…

In Express Pharma’s 20th year, we present the second installment of thought leaders predicting changes to watch out for in the…

In a free-wheeling conversation with Viveka Roychowdhury, Patrick Figgis, Global Health Leader, PwC and Sujay Shetty,…

There is a dire need for carefully balancing the requirements of the public and the industry, opine Bhavik Narsana, Partner,…

The next decade or so in the pharmaceutical patent space in India will be interesting to watch out for. As more product patents…

During the quarter under review, profit before tax was Rs 4.4 crore as against Rs 21.6 crore in the previous corresponding period…

The last few years have been painful for India’s biotech sector but many companies have turned adversity into opportunity. Express…

After three consecutive years of negative EBITDA, Panacea Biotec looks set to script a successful revival. Dr Rajesh Jain, Joint…

Since the past few years, lack of funding, distrustful investors, and weak global economic conditions have made survival a tall…

Providing innovative, high value, sustainable ingredients, in particular for the health, wellness and nutrition segment, Evolva…